Welcome to our dedicated page for Archimedes Tech SPAC Partners II Co. SEC filings (Ticker: ATII), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Archimedes Tech SPAC Partners II Co. (ATII) SEC filings page on Stock Titan is intended to provide access to the company’s regulatory documents once they are available, along with AI-powered analysis. Archimedes Tech SPAC Partners II Co. is described as a blank check company and special purpose acquisition company in the financial services sector, organized as a Cayman Islands exempted company and listed on The Nasdaq Global Market through its units and expected separate trading of ordinary shares and warrants.
Although no specific SEC filings are listed in the provided data, the company’s press releases note that registration statements relating to its securities were declared effective by the U.S. Securities and Exchange Commission in connection with its initial public offering. Over time, investors can typically look to SEC filings for detailed information about a SPAC’s structure, risk factors, use of proceeds from its offering, and any proposed or completed business combination transactions.
On this page, Stock Titan’s platform is designed to surface key filing types for Archimedes Tech SPAC Partners II Co., such as registration statements and, when applicable, periodic reports and transaction-related documents. AI-powered summaries help explain the contents of lengthy filings in plain language, highlighting important sections and clarifying complex terms. Real-time updates from the EDGAR system ensure that new filings appear promptly, while tools for reviewing forms related to securities offerings and other disclosures make it easier to understand the company’s regulatory history.
For a SPAC and shell company like Archimedes Tech SPAC Partners II Co., these filings are central to understanding its capital structure, the terms of its units, ordinary shares and warrants, and any future steps it may take toward a business combination, as reflected in its official SEC documents.
Archimedes Tech SPAC Partners II Co. filed its annual report outlining its structure, IPO proceeds and current cash position as a newly formed SPAC. The company completed an IPO on February 12, 2025, selling 23,000,000 units at $10.00 each for gross proceeds of $230,000,000, plus 840,000 private placement units for $8,400,000.
After costs, $231,150,000 was deposited into a trust account for public shareholders. As of December 31, 2025, the trust balance had grown to $239,860,969, invested in short-term U.S. government securities, while cash outside the trust was $1,362,766 for working capital.
The SPAC reported net income of $7,986,738 for 2025, driven mainly by interest on trust investments, and no operating revenues. It has up to 21 months from the IPO closing, until November 12, 2026, to complete an initial business combination in technology sectors such as artificial intelligence, cloud services and automotive technology, or it will liquidate and return trust funds to public shareholders.
Barclays PLC filed an amended Schedule 13G to report its beneficial ownership in Archimedes Tech SPAC Partner common stock. Barclays reports beneficial ownership of 1,148,590 common shares, representing 3.88% of the outstanding class as of the reported date.
Barclays states it has sole voting and sole dispositive power over all 1,148,590 shares, with no shared voting or dispositive power. The filing confirms that the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the company.
Archimedes Tech SPAC Partners II Co. reported Q3 2025 results highlighting interest-driven income and a strong trust balance. Net income was $2,403,801 for the quarter, primarily from $2,546,478 of interest earned on the Trust Account, offset by $159,842 of general and administrative expenses.
As of September 30, 2025, the Trust Account held $237,491,299 and cash outside the trust was $1,409,116. The company completed its IPO on February 12, 2025, selling 23,000,000 units at $10.00 per unit (including the full 3,000,000 over-allotment), for $230,000,000 in gross proceeds, and a concurrent private placement of 840,000 units for $8,400,000. A deferred underwriting fee of $8,050,000 remains payable upon a business combination.
Ordinary shares subject to possible redemption totaled 23,000,000 at a redemption value of $10.33 per share as of September 30, 2025. Warrants outstanding were 11,920,000, each whole warrant exercisable at $11.50 per share under stated conditions. As of November 7, 2025, there were 29,590,000 ordinary shares issued and outstanding.